Detail akcie Intuitive Surgical online

Business Summary: Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Intuitive Surgical, Inc. revenues increased 14% to $7.12B. Net income increased 36% to $1.8B. Revenues reflect Instruments and accessories segment increase of 22% to $4.28B, Services segment increase of 14% to $1.17B, U.S. segment increase of 13% to $4.69B, Outside of United states segment increase of 18% to $2.44B. Net income benefited from Interest and other income.